Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice

Fig. 3

Comparison of cell-based therapeutic efficiency mice with MI. a Representative M-mode echocardiographic images of sham-operated, saline-treated, CD51−bMSC-treated and CD51+bMSC-treated mice. b Heart function analysis; quantification of LVEF, LVFS, LVESV and LVEDV (n = 3 or 4). c Triphenyl tetrazolium chloride (TTC) staining of the heart sections (short axis) at 21 days after treatment. d The proportion of the infarct myocardium area was calculated as the percentage of the left ventricular area (the total area of the five heart sections were used for quantification, n = 3). e Masson’s trichrome staining of the heart sections (long axis) at 21 days after treatment. Data in all panels are presented as the mean ± SD, ns P > 0.05, *P < 0.05. LVEF, left ventricular (LV) ejection fraction; LVFS, LV fractional shortening; LVESV, LV end-systolic volume; LVEDV, LV end-diastolic volume

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512